drug
Exosome-Based Vaccine
Phase 1updated 5mo agoby $CAPR CAPRICOR THERAPEUTICS, INC.
Phase 1community read0 votes
all catalysts(0)
nothing on the calendar yet
News(2)
- Capricor investor calls for change as company awaits decision on Duchenne candidateKaos Capital in a letter to other Capricor Therapeutics shareholders called for “an immediate meeting, board change, and capital-preservation plan.” The biotech recently put all other pipeline work…biospace · 1mo ago
- Capricor soars on potential FDA review extension, filing amendmentsCapricor Therapeutics’ CEO Linda Marbán believes the FDA is willing to work with the biotech as the Aug. 22 deadline approaches for its Duchenne muscular dystrophy cell therapy deramiocel, with the…biospace · 1mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that